Literature DB >> 25489261

Use of pet in the management of non-small-cell lung cancer in Canada.

E Vorauer1, C Louzado2, K DeCaria2, J Hernandez2, R Rahal2, J Niu2, G Lockwood3, H Bryant4.   

Abstract

Entities:  

Year:  2014        PMID： 25489261      PMCID： PMC4257117          DOI： 10.3747/co.21.2271

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  2 in total

1.  Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007.

Authors:  Michaela A Dinan; Lesley H Curtis; William R Carpenter; Andrea K Biddle; Amy P Abernethy; Edward F Patz; Kevin A Schulman; Morris Weinberger
Journal:  Radiology       Date:  2013-02-15       Impact factor: 11.105

2.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Authors:  Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Paul Verboom; Johan C van Mourik; Pieter E Postmus; Maarten Boers; Gerrit J J Teule
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.